These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19521960)

  • 21. Macrophage inhibitory cytokine-1 (MIC-1/GDF15) gene deletion promotes cancer growth in TRAMP prostate cancer prone mice.
    Husaini Y; Lockwood GP; Nguyen TV; Tsai VW; Mohammad MG; Russell PJ; Brown DA; Breit SN
    PLoS One; 2015; 10(2):e0115189. PubMed ID: 25695521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma.
    Schiegnitz E; Kämmerer PW; Koch FP; Krüger M; Berres M; Al-Nawas B
    Oral Oncol; 2012 Jul; 48(7):608-14. PubMed ID: 22341306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma.
    Strojnik T; Smigoc T; Lah TT
    Anticancer Res; 2014 Jan; 34(1):339-47. PubMed ID: 24403485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage inhibitory cytokine-1/growth differentiation factor 15 as a marker of cognitive ageing and dementia.
    Jiang J; Wen W; Sachdev PS
    Curr Opin Psychiatry; 2016 Mar; 29(2):181-6. PubMed ID: 26731555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First Behavioural Characterisation of a Knockout Mouse Model for the Transforming Growth Factor (TGF)-β Superfamily Cytokine, MIC-1/GDF15.
    Low JK; Ambikairajah A; Shang K; Brown DA; Tsai VW; Breit SN; Karl T
    PLoS One; 2017; 12(1):e0168416. PubMed ID: 28081177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocyte growth factor in cerebrospinal fluid is associated with mortality and recurrence of glioblastoma, and could be of prognostic value.
    Garcia-Navarrete R; Garcia E; Arrieta O; Sotelo J
    J Neurooncol; 2010 May; 97(3):347-51. PubMed ID: 19856144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased concentrations of transforming growth factor beta1 and beta2 in the plasma of patients with glioblastoma.
    Schneider T; Sailer M; Ansorge S; Firsching R; Reinhold D
    J Neurooncol; 2006 Aug; 79(1):61-5. PubMed ID: 16614941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal Bottom-Up Proteomics of Serum, Serum Extracellular Vesicles, and Cerebrospinal Fluid Reveals Candidate Biomarkers for Early Detection of Glioblastoma in a Murine Model.
    Greco F; Anastasi F; Pardini LF; Dilillo M; Vannini E; Baroncelli L; Caleo M; McDonnell LA
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein biomarker identification in the CSF of patients with CNS lymphoma.
    Roy S; Josephson SA; Fridlyand J; Karch J; Kadoch C; Karrim J; Damon L; Treseler P; Kunwar S; Shuman MA; Jones T; Becker CH; Schulman H; Rubenstein JL
    J Clin Oncol; 2008 Jan; 26(1):96-105. PubMed ID: 18056677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth differentiation factor 15 increases in both cerebrospinal fluid and serum during pregnancy.
    Andersson-Hall U; Svedin P; Mallard C; Blennow K; Zetterberg H; Holmäng A
    PLoS One; 2021; 16(5):e0248980. PubMed ID: 34043633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myelin basic protein in the cerebrospinal fluid of patients with brain tumors.
    Nakagawa H; Yamada M; Kanayama T; Tsuruzono K; Miyawaki Y; Tokiyoshi K; Hagiwara Y; Hayakawa T
    Neurosurgery; 1994 May; 34(5):825-33; discussion 833. PubMed ID: 7519757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
    Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B
    Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation.
    Xu J; Kimball TR; Lorenz JN; Brown DA; Bauskin AR; Klevitsky R; Hewett TE; Breit SN; Molkentin JD
    Circ Res; 2006 Feb; 98(3):342-50. PubMed ID: 16397142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation.
    Monteiro-Reis S; Leça L; Almeida M; Antunes L; Monteiro P; Dias PC; Morais A; Oliveira J; Henrique R; Jerónimo C
    Eur J Cancer; 2014 Jan; 50(1):226-33. PubMed ID: 24100025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The angiopoietin 1/angiopoietin 2 balance as a prognostic marker in primary glioblastoma multiforme.
    Sie M; Wagemakers M; Molema G; Mooij JJ; de Bont ES; den Dunnen WF
    J Neurosurg; 2009 Jan; 110(1):147-55. PubMed ID: 18991494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A highly sensitive and specific chemiluminescent enzyme immunoassay for placental alkaline phosphatase in the cerebrospinal fluid of patients with intracranial germinomas.
    Watanabe S; Aihara Y; Kikuno A; Sato T; Komoda T; Kubo O; Amano K; Okada Y; Koyamaishi Y
    Pediatr Neurosurg; 2012; 48(3):141-5. PubMed ID: 23429277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma.
    Corre J; Labat E; Espagnolle N; Hébraud B; Avet-Loiseau H; Roussel M; Huynh A; Gadelorge M; Cordelier P; Klein B; Moreau P; Facon T; Fournié JJ; Attal M; Bourin P
    Cancer Res; 2012 Mar; 72(6):1395-406. PubMed ID: 22301101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of glioblastoma in biofluids.
    Figueroa JM; Carter BS
    J Neurosurg; 2018 Aug; 129(2):334-340. PubMed ID: 29053069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamics of expression of growth differentiation factor 15 in normal and PIN development in the mouse.
    Noorali S; Kurita T; Woolcock B; de Algara TR; Lo M; Paralkar V; Hoodless P; Vielkind J
    Differentiation; 2007 Apr; 75(4):325-36. PubMed ID: 17286605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.
    Shen F; Zhang Y; Yao Y; Hua W; Zhang HS; Wu JS; Zhong P; Zhou LF
    Neurosurg Rev; 2014 Jul; 37(3):367-80; discussion 380. PubMed ID: 24781189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.